Customer Service: 866-788-9007
×

Insurance Coverage

Our Promise To Our Customers

Castle Biosciences has, to date, processed all Castle test orders for U.S.-based physicians regardless of the patient’s ability to pay.

The Company works with Medicare, commercial insurance providers and, in some cases, the physician’s institution to secure payment coverage for its diagnostic and prognostic tests. Castle submits insurance claims on the patient’s behalf, engages with physician offices to obtain necessary documentation, and follows through to payment. Castle Biosciences believes a patient’s ability to pay for the test should not affect their care, and has put a generous Patient Assistance Program in place for those who need it.

SCCHCP-RiskId.svg

Order DecisionDx-SCC

For Information

Call: 866-788-9007

Podcast

A Review of the DecisionDx-SCC Clinical Validation Study in Future Oncology

by Dr. Sherrif F. Ibrahim

Enhanced Metastatic Risk Assessment in Cutaneous Squamous Cell Carcinoma with the 40-Gene Expression Profile Test: An Interview with the Lead Author of DecisionDx-SCC’s Validation Study.

Speaker: Sherrif F. Ibrahim, MD, PhD., Assistant Professor, Department of Dermatology, University of Rochester Medical Center

Video Webinar

An Introduction to DecisionDx–SCC by Dr. Jason Newman, UPenn

AHNS DecisionDx–SCC Webinar: Identifying the Risk of Metastasis in cSCC and cSCC-HN Patients

Speaker: Dr. Jason Newman, Professor of Otorhinolaryngology - Head and Neck Surgery, University of Pennsylvania

Scroll to Top